Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
An Acad Bras Cienc ; 96(2): e20240014, 2024.
Article in English | MEDLINE | ID: mdl-38747842

ABSTRACT

Despite the prevalence of substance use during pregnancy, studies focusing exclusively on Neonatal Intensive Care Units (NICU) admissions remain limited. This study investigates the impact of maternal use of tobacco, alcohol, and/or crack, on neonatal outcomes among infants admitted to three Brazilian NICUs. Additionally, the investigation explores the impact of substance use on DNA damage in newborns. Over a one-year period, data from 254 newborns were collected through medical records, accompanied by blood samples. Findings revealed that 16.1% of newborns had mothers reporting substance use during pregnancy. Significant associations were found between maternal substance use and adverse neonatal outcomes, including low birth weight, preterm birth, and sexually transmitted infections. Maternal variables linked to substance use encompassed non-white skin color, low education, non-masonry housing, lower income, diseases in other children, and fewer prenatal consultations. Notably, neonatal DNA damage showed no significant association with substance use. Our results underscore the substantial impact of maternal substance use on NICU-admitted infants, emphasizing the necessity for targeted interventions that address both neonatal health and maternal well-being, thereby underscoring the crucial role of comprehensive care in NICU settings.


Subject(s)
Alcohol Drinking , Intensive Care Units, Neonatal , Humans , Pregnancy , Female , Infant, Newborn , Brazil/epidemiology , Adult , Alcohol Drinking/adverse effects , Pregnancy Complications , Male , Young Adult , Pregnancy Outcome , Infant, Low Birth Weight , Crack Cocaine/adverse effects , Cocaine-Related Disorders/epidemiology , Risk Factors , Socioeconomic Factors , DNA Damage , Prenatal Exposure Delayed Effects
2.
J Inorg Biochem ; 239: 112062, 2023 02.
Article in English | MEDLINE | ID: mdl-36403436

ABSTRACT

The interaction between CuII, FeIII and MnII complexes, derived from the ligands 1-[bis(pyridine-2-ylmethyl)amino]-3-chloropropan-2-ol (hpclnol) and bis(pyridine-2-ylmethyl)amine (bpma), and the free radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl (DPPH) and reactive oxygen species (ROS), was investigated by colorimetric and EPR (Electron Paramagnetic Resonance) techniques. A comparison between these results and those reported to [Mn(salen)Cl] or EUK-8 was also addressed. EPR studies allowed us the identification of intermediates species such as superoxide­copper(I) and superoxide­copper(II), a mixed-valence FeIIIFeII species and a 16-line feature attributed to MnIII-oxo-MnIV species. The biomarker malondialdehyde (MDA) was determined by TBARS assay in S. cerevisiae cells, and the determination of the IC50 indicate that the antioxidant activity shown dependence on the metal center (CuII ≈ FeIII > MnII ≈ [Mn(salen)Cl]. The lipid peroxidation attenuation was also investigated in liver homogenates obtained from Swiss mice and the IC50 values were in the nanomolar concentrations. We demonstrated here that all the complexes interact with the free radical DPPH and with ROS (H2O2, O2•- and hydroxyl radical), enhancing the cellular protection against oxidative stress generated by hydroxyl radical, employing two experimental model systems, S. cerevisiae (in vivo) and mouse liver (ex vivo).


Subject(s)
Saccharomyces cerevisiae , Superoxides , Mice , Animals , Saccharomyces cerevisiae/metabolism , Lipid Peroxidation , Reactive Oxygen Species , Hydroxyl Radical , Copper/chemistry , Ferric Compounds , Hydrogen Peroxide , Free Radicals , Superoxide Dismutase/metabolism , Liver/metabolism , Pyridines
SELECTION OF CITATIONS
SEARCH DETAIL